Superdisintegrants Market Report

Superdisintegrants Market Analysis By Product (Croscarmellose sodium, Crospovidone, Sodium starch glycolate, Ion exchange resin), By Dosage Form (Tablets and Capsules, Mouth-dissolving Films), And Segment Forecasts, 2014 - 2025

Published: August 2017  |  100 Pages  |  Format: PDF  |  Report ID: GVR-1-68038-539-7

Industry Insights

The global superdisintegrants market size was valued at around USD 258.6 million in 2016 and is expected to grow at a CAGR of 7.2% over the forecast period. Factors such as growing generic drugs market, geriatric and pediatric population who have difficulty in swallowing tablet/capsules and development of new superdisintegrants for the pharmaceutical industry is driving growth of the market.

Furthermore, increasing pharmaceutical consumption by the global population is in turn increasing the demand for various superdisintegrants. Pharmaceuticals now account for about 20% of total health spending in Organization for Economic Co-operation and Development (OECD) countries; out of which Canada has emerged out to be among the top pharmaceutical spender on the OECD list.

U.S. superdisintegrants market revenue, by product, 2014 - 2025 (USD Million)

U.S. superdisintegrants market

Product Insights

Crospovidone dominated the product segment in 2016. Crospovidone has the ability to stabilize the amorphous state of drugs due to inhibition of drug recrystallization and a rapid solidification rate. In addition, crospovidone has excellent disintegration and dissolution enhancing effect, which is usually used in the preparation of tablets, granules and capsules. All these factors would together propel the growth of crospovidone segment during the forecast period.

However, others segment which includes natural superdisintegrants such as Isapghula husk, gellan gum, and locust bean gum is expected to grow at the highest CAGR during the forecast period. It has instant swelling features when it comes into contact with water due to its high hydrophilic nature, which results in rapid disintegration of tablets. Apart from these superdisintegrants, researchers are continuously investigating for novel disintegrating agents. It includes testing of modified natural products, such as, chitin, chitosan, polymerized agar acrylamide, xylem, cross-linked carboxymethylguar and modified tapioca starch.

Dosage Form Insights

Tablets and capsules segment dominated the market in 2016. Tablets have longer shelf life, accurate dosing, and are cost-effective. Disintegrants are one of the most significant excipients of tablet and capsule formulation, and are added to induce breakup, when it encounters aqueous fluid. Tablets and capsules have quick-dissolving dosage form recognized by FDA and are listed in the approved drug products with therapeutic equivalence evaluations, which would boost the growth of the segment. Number of disintegrants used for multifunctional tablet and capsule formulation includes starch (and its derivatives), crospovidone, cellulose, and others.

Mouth-dissolving films segment is expected to witness the highest growth during the forecast period. Advantages and unique properties, availability of larger surface area for rapid disintegrating and dissolution in the oral cavity, accurate dosing, rapid onset of action, and improved patient compliance for pediatric population are a few factors contributing towards the growth of the segment.

Global superdisintegrant market revenue, by product, 2016 (%)

Global superdisintegrant market

Regional Insights

North America dominated the superdisintegrants industry with the largest revenue share in 2016. Increasing demand for generic drugs, better innovation in the manufacture of superdisintegrants and the techniques used to manufacture them are a few high impact rendering drivers for the market. In addition, North America is home to some of the most significant players who are operating in the field of superdisintegrants market.

On the other hand, Asia Pacific is expected to show the fastest growth during the forecast period. Factors such as increasing outsourcing of excipients including superdisintegrants, manufacturing of new superdisintegrants, and adoption of novel technologies (novel drug delivery system) are expected to drive growth in the Asia Pacific region.

Competitive Insights

Currently, the global superdisintegrants market is fragmented in nature with a number of players. Some of the top companies operating in this industry are Ashland Global Holdings Inc., Roquette Frères S.A., FMC Corporation, DFE Pharma, Huber Corporation, Nippon Soda Co., Ltd. The Dow Chemical Company and BASF SE. Mergers, acquisitions, and regional expansion are the key strategic undertakings of these companies to increase the market share during the forecast period.

Report Scope

Attribute

Details

Base year for estimation

2016

Actual estimates/Historical data

2014 - 2015

Forecast period

2017 - 2025

Market representation                                                

Revenue in USD Million and CAGR from 2017 to 2025

Regional scope

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Country scope

U.S., Canada, U.K., Germany, Japan, China, Brazil, Mexico, South Africa

Report coverage             

Revenue forecast, company share, competitive landscape, growth factors and trends

15% free customization scope (equivalent to 5 analyst working days)

If you need specific market information, which is not currently within the scope of the report, we will provide it to you as a part of customization


Segments Covered in the Report

This report forecasts revenue growth at global, regional & country levels as well as provides an analysis on the latest trends and opportunities in each of the sub-segments from 2014 to 2025. For the purpose of this study, Grand View Research has segmented the global superdisintegrants market on the basis of product, dosage form, and region:

  • Product Outlook (Revenue, USD Million, 2014 - 2025)

    • Croscarmellose sodium

    • Crospovidone

    • Sodium starch glycolate

    • Ion exchange resin

    • Others

  • Dosage Form Outlook (Revenue, USD Million, 2014 - 2025)

    • Tablets and Capsules

    • Mouth-dissolving Films

  • Regional Outlook (Revenue, USD Million, 2014 - 2025)

    • North America

      • U.S.

      • Canada

    • Europe

      • U.K.

      • Germany

    • Asia Pacific

      • Japan

      • China

    • Latin America

      • Brazil

      • Mexico

    • MEA

      • South Africa

Key questions answered by the report
Request for Customization

Choose License Type

Single User - $4,950
Library Access - $7,950

Buy Chapters or Sections

Avail customized purchase options to meet your research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

  • Research support

    24/5 Research support

    Get your queries resolved from an industry expert. Request for a free product review before report purchase.

  • Custom research service

    Custom research service

    Speak to the report author to design an exclusive study to serve your research needs.

  • Quality assurance

    Quality assurance

    A testimonial for service excellence represented in the form of BBB "A" Accreditation.

  • BBB Rating dandb
  • Information security

    Information security

    Your personal and confidential information is safe and secure.

  • BOA